https://biotechmorning.com/news/blood-test-alzheimers-replaces-pet-scan Biotech Morning en 2026-08-21T14:14:34.724Z A $200 Blood Draw Could Replace a $3,000 Brain Scan for Alzheimer's https://biotechmorning.com/news/boehringer-mystery-safety-scare-japan Biotech Morning en 2026-08-21T14:13:41.460Z Boehringer's Mystery Safety Scare in Japan https://biotechmorning.com/news/roche-750-million-oregon-biologics-manufacturing Biotech Morning en 2026-08-21T14:12:55.392Z Roche Just Bet $750 Million That Oregon Is the Future of Drug Manufacturing https://biotechmorning.com/news/teva-appeals-court-ira-drug-pricing-challenge Biotech Morning en 2026-08-21T14:12:11.706Z Teva Just Cracked Open a Door Big Pharma Thought Was Locked https://biotechmorning.com/news/149-pill-blow-up-glp1-war Biotech Morning en 2026-08-21T14:11:25.731Z The $149 Pill That Could Blow Up the GLP-1 War https://biotechmorning.com/news/ultragenyx-gsd-ia-gene-therapy-fda-approval Biotech Morning en 2026-08-21T14:10:38.875Z The $2.7 Million Shot That Replaces a Lifetime of Eating Cornstarch https://biotechmorning.com/news/biontech-two-drug-cocktail-lung-cancer Biotech Morning en 2026-08-21T14:09:53.889Z BioNTech's Two-Drug Cocktail Nobody Has Tried in Lung Cancer https://biotechmorning.com/news/bms-chai-discovery-ai-antibody-deal Biotech Morning en 2026-08-21T14:09:06.644Z BMS Just Hired a Robot to Design Its Next Blockbuster Antibody https://biotechmorning.com/news/amgen-walks-away-tscan-tcr-therapy-deal Biotech Morning en 2026-08-21T14:08:19.139Z Amgen Just Walked Away From a Half-Billion-Dollar Bet on T-Cell Therapy https://biotechmorning.com/news/fda-downclassifies-oncology-diagnostics Biotech Morning en 2026-08-20T14:18:41.209Z The FDA Just Made It Way Easier to Compete in Cancer Diagnostics https://biotechmorning.com/news/mini-brains-five-years-alive-nature-study Biotech Morning en 2026-08-20T14:17:53.186Z The Mini-Brains That Refused to Die https://biotechmorning.com/news/biomarin-alesta-oral-therapy-hypophosphatasia Biotech Morning en 2026-08-20T14:17:08.054Z BioMarin Just Bet $275M That You'll Swallow a Pill Instead of Taking a Shot https://biotechmorning.com/news/jazz-actio-kcnt1-epilepsy-acquisition Biotech Morning en 2026-08-20T14:16:22.498Z Jazz Just Bet $1.3 Billion on a Channel Nobody's Cracked https://biotechmorning.com/news/fop-first-treatment-fda-approval-pasatru Biotech Morning en 2026-08-20T14:15:36.218Z The Disease That Turns Muscle Into Bone Just Got Its First Real Treatment https://biotechmorning.com/news/thymus-biotech-tolerance-bio-neoimmune-deal Biotech Morning en 2026-08-20T14:14:50.816Z The Organ You Forgot About Might Be Biotech's Next Big Bet https://biotechmorning.com/news/lsd-pill-aces-late-stage-anxiety-trial Biotech Morning en 2026-08-20T14:14:01.155Z An LSD Pill Just Aced a Late-Stage Anxiety Trial. Yes, Really. https://biotechmorning.com/news/jj-returns-car-t-rights-abelzeta-fda-ind Biotech Morning en 2026-08-20T14:13:15.543Z J&J Handed Back the Keys. This Tiny Biotech Just Started the Engine. https://biotechmorning.com/news/huidagene-patient-death-disclosure-delay Biotech Morning en 2026-08-20T14:12:26.654Z A Boy Died a Year Ago. The Company Just Told Us. https://biotechmorning.com/news/fda-next-boss-heidi-overton-nomination Biotech Morning en 2026-08-20T14:11:43.860Z The FDA's Next Boss Has Never Run a Regulatory Agency. That's the Point.